Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasis
Sign Up to like & getrecommendations! Published in 2020 at "Rheumatology International"
DOI: 10.1007/s00296-020-04573-w
Abstract: The aim of this study was to generate practical recommendations to assist rheumatologists and dermatologists in the management of cardiovascular (CV) comorbidities in patients with moderate-to-severe psoriasis (MS-PSO) and psoriatic arthritis (PsA). A two-round Delphi… read more here.
Keywords: cardiovascular comorbidities; comorbidities patients; management; management cardiovascular ... See more keywords
Just go with the flow
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Nuclear Cardiology"
DOI: 10.1007/s12350-020-02244-8
Abstract: There are reasons to pursue the study of myocardial blood flow and its alterations in patients with rheumatic diseases (RDs) not the least of which is the fact that cardiovascular (CV) disease is a leading… read more here.
Keywords: risk; flow; severe psoriasis; cardiology ... See more keywords
Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Clinical Dermatology"
DOI: 10.1007/s40257-017-0274-0
Abstract: BackgroundPsoriasis is a common skin disease and moderate to severe psoriasis is associated with a dose-dependent risk for metabolic and cardiovascular morbidity. It has previously been speculated that women have less severe psoriasis, as men… read more here.
Keywords: area; severity; severe psoriasis; psoriasis ... See more keywords
Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Clinical Dermatology"
DOI: 10.1007/s40257-017-0322-9
Abstract: Pharmacogenetics is the study of variations in DNA sequence related to drug response. Moreover, the evolution of biotechnology and the sequencing of human DNA have allowed the creation of pharmacogenomics, a branch of genetics that… read more here.
Keywords: pharmacogenomics moderate; pharmacogenetics pharmacogenomics; response; severe psoriasis ... See more keywords
Medical resource consumption of moderate/severe psoriasis in a private health organization of Buenos Aires, Argentina☆☆☆
Sign Up to like & getrecommendations! Published in 2019 at "Anais Brasileiros de Dermatologia"
DOI: 10.1016/j.abd.2019.04.007
Abstract: Background Despite the economic burden of psoriasis for patients and societies, scant information exists regarding the impact and burden of the disease in Argentina. Objective The objective of this study was to estimate medical resource… read more here.
Keywords: resource consumption; medical resource; severe psoriasis; psoriasis ... See more keywords
Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience.
Sign Up to like & getrecommendations! Published in 2021 at "Actas dermo-sifiliograficas"
DOI: 10.1016/j.ad.2021.05.017
Abstract: Childhood-onset psoriasis generally follows an indolent course but patients with moderate or severe disease may require systemic treatment. The aim of this study was to determine the relative proportion of children and young people aged… read more here.
Keywords: severe psoriasis; moderate severe; treatment; psoriasis ... See more keywords
Number needed to treat and costs per responder among biologic treatments for moderate-to-severe psoriasis: a network meta-analysis
Sign Up to like & getrecommendations! Published in 2018 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2018.1457516
Abstract: Abstract Background: The clinical benefits of biologic therapies for moderate-to-severe psoriasis are well established, but wide variations exist in patient response. Objectives: To determine the number needed to treat (NNT) to achieve a 75% and… read more here.
Keywords: pasi; severe psoriasis; cost; moderate severe ... See more keywords
Alterations in Retinal Vascularity in Severe Psoriasis.
Sign Up to like & getrecommendations! Published in 2023 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2023.2166536
Abstract: PURPOSE To evaluate the changes in retinal vascularity in patients with severe psoriasis. MATERIALS AND METHODS Patients with severe psoriasis [psoriasis area-severity index (PASI) >10] who did not get any systemic treatment in the last… read more here.
Keywords: retinal vascularity; alterations retinal; vascularity severe; severe psoriasis ... See more keywords
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2016.1249820
Abstract: Abstract Background: Scalp is a frequently affected and difficult-to-treat area in psoriasis patients. Objective: We assessed the efficacy of ixekizumab in the treatment of patients with scalp psoriasis over 60 weeks using the Psoriasis Scalp… read more here.
Keywords: ixekizumab; treatment; severe psoriasis; psoriasis ... See more keywords
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2020.1800577
Abstract: Abstract Objectives We aimed to evaluate the effectiveness, safety and tolerability of guselkumab in a real-life setting. Methods A prospective, observational, single-center, real-life study including patients under guselkumab treatment from October 2018 to January 2020… read more here.
Keywords: severe psoriasis; moderate severe; week 001; week ... See more keywords
Tailored biological treatment for patients with moderate-to-severe psoriasis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2023.2141226
Abstract: ABSTRACT Introduction Psoriasis is a common, chronic immune-mediated skin disease frequently associated to inflammatory and metabolic comorbidities. About 20–30% of patients are affected by moderate-to-severe psoriasis and require a systemic treatment, which include traditional and… read more here.
Keywords: treatment patients; moderate severe; treatment; biological treatment ... See more keywords